alendronate has been researched along with Mastocytosis, Systemic in 2 studies
alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.
Mastocytosis, Systemic: A group of disorders caused by the abnormal proliferation of MAST CELLS in a variety of extracutaneous tissues including bone marrow, liver, spleen, lymph nodes, and gastrointestinal tract. Systemic mastocytosis is commonly seen in adults. These diseases are categorized on the basis of clinical features, pathologic findings, and prognosis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Systemic mastocytosis is a rare but well-recognised cause of secondary osteoporosis, accounting for about 1." | 1.35 | Systemic mastocytosis presenting as osteoporosis--a case report. ( Dhillon, V; Mathew, R; Shepherd, P, 2009) |
| "Systemic mastocytosis is a rare and occasionally aggressive condition that raises major diagnostic challenges." | 1.32 | Aggressive systemic mastocytosis. ( Bertin, P; Inaoui, R; Jaccard, A; Petit, B; Trèves, R, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mathew, R | 1 |
| Dhillon, V | 1 |
| Shepherd, P | 1 |
| Inaoui, R | 1 |
| Petit, B | 1 |
| Jaccard, A | 1 |
| Bertin, P | 1 |
| Trèves, R | 1 |
2 other studies available for alendronate and Mastocytosis, Systemic
| Article | Year |
|---|---|
Systemic mastocytosis presenting as osteoporosis--a case report.
Topics: Alendronate; Bone Density Conservation Agents; Diagnosis, Differential; Exanthema; Humans; Lumbar Ve | 2009 |
Aggressive systemic mastocytosis.
Topics: Aged; Alendronate; Bone Marrow Cells; Fatal Outcome; Female; Humans; Interferon-alpha; Leukemia, Mye | 2003 |